A Case of Erythroplasia of Queyrat Treated with Imiquimod 5% Cream and Excision
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Imiquimod is a new immunomodulating agent with antitumor and antiviral properties that has been shown to be clinically effective in various kinds of skin diseases, including precancerous dermatoses. Erythroplasia of Queyrat is a carcinoma in situ that mainly occurs on the glans penis. There are several non-invasive treatment options for erythroplasia of Queyrat such as photodynamic therapy, cryosurgery and applying various kinds of topical agents. We now report a case of typical erythroplasia of Queyrat on glans penis associated with human papillomavirus type 16 infection that was treated by imiquimod 5% cream and the subsequent excision of an imiquimod-resistant penile lesion.
Abstract
Imiquimod is a new immunomodulating agent with antitumor and antiviral properties that has been shown to be clinically effective in various kinds of skin diseases, including precancerous dermatoses. Erythroplasia of Queyrat is a carcinoma in situ that mainly occurs on the glans penis. There are several non-invasive treatment options for erythroplasia of Queyrat such as photodynamic therapy, cryosurgery and applying various kinds of topical agents. We now report a case of typical erythroplasia of Queyrat on glans penis associated with human papillomavirus type 16 infection that was treated by imiquimod 5% cream and the subsequent excision of an imiquimod-resistant penile lesion.
참고문헌 (13)
- Graham JH, "Erythroplasia of Queyrat. A clinicopathologic and histochemical study", Cancer, 32, pp.1396~1414 (1973)
- Mikhail GR, "Cancers, precancers, and pseudocancers on the male genitalia. A review of clinical appearances, histopathology, and management", J Dermatol Surg Oncol, 6, pp.1027~1035 (1980)
- Peterka ES, "An association between Bowen's disease and internal cancer", Arch Dermatol, 84, pp.623~629 (1961)
- Kao GF, "Carcinoma arising in Bowen's disease", Arch Dermatol, 122, pp.1124~1126 (1986)
- Wieland U, "Erythroplasia of Queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ", J Invest Dermatol, 115, pp.396~401 (2000)
- Meyer T, "Importance of human papillomaviruses for the development of skin cancer", Cancer Detect Prev, 25, pp.533~547 (2001)
- Stables GI, "Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy", Br J Dermatol, 140, pp.514~517 (1999)
- Perry CM, "Topical imiquimod: a review of its use in genital warts", Drugs, 58, pp.375~390 (1999)
- Hemmi H, "Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway", Nat Immunol, 3, pp.196~200 (2002)
- Miller RL, "Imiquimod applied topically: a novel immune response modifier and new class of drug", Int J Immunopharmacol, 21, pp.1~14 (1999)
- Arlette JP, "Treatment of Bowen's disease and erythroplasia of Queyrat", Br J Dermatol, 149(66), pp.43~49 (2003)
- Micali G, "Erythroplasia of Queyrat treated with imiquimod 5% cream", J Am Acad Dermatol, 55, pp.901~903 (2006)
- van Seters M, "Imiquimod in the treatment of multifocal vulvar intraepithelial neoplasia 2", 3. Results of a pilot study, 2002, pp.47, 701~705